Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up

Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up

Purpose/Objective(s): The current study reports long-term overall survival (OS) and biochemical freedom from recurrence (BFFR) after stereotactic body radiation therapy (SBRT) for men with intermediate and high-risk prostate cancer in a single community hospital setting with early adoption.Materials...

Full description

Bibliographic Details
Main Authors: Anthony Ricco, Gabrielle Barbera, Rachelle Lanciano, Jing Feng, Alexandra Hanlon, Alicia Lozano, Michael Good, Stephen Arrigo, John Lamond, Jun Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
SBRT (stereotactic body radiation therapy)
high risk prostate cancer
prostate SBRT treatment
intermediate risk prostate cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01505/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01505/full

Similar Items